Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 571

The DOI matches its Crossref record; 342 of the 342 references it cites were found in a registry or an index.

Role of PI3K/AKT pathway in cancer: the framework of malignant behavior

Open access
Jiang, Ningni, Dai, Qijie, Su, Xiaorui, Fu, Jianjiang, Feng, Xuancheng, Peng, Juan·2020·Molecular Biology Reports

Abstract

Given that the PI3K/AKT pathway has manifested its compelling influence on multiple cellular process, we further review the roles of hyperactivation of PI3K/AKT pathway in various human cancers. We state the abnormalities of PI3K/AKT pathway in different cancers, which are closely related with tumorigenesis, proliferation, growth, apoptosis, invasion, metastasis, epithelial–mesenchymal transition, stem-like phenotype, immune microenvironment and drug resistance of cancer cells. In addition, we investigated the current clinical trials of inhibitors against PI3K/AKT pathway in cancers and found that the clinical efficacy of these inhibitors as monotherapy has so far been limited despite of the promising preclinical activity, which means combinations of targeted therapy may achieve better efficacies in cancers. In short, we hope to feature PI3K/AKT pathway in cancers to the clinic and bring the new promising to patients for targeted therapies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11033-020-05435-1

Cites

342 of 342 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

15 retracted

Show all 342 references

Cited by

See all 571

Metadata

Authors
Jiang, N., Dai, Q., Su, X., Fu, J., Feng, X., & Peng, J.
Venue
Molecular Biology Reports
Published
2020-04-24
Volume
47
Issue
6
Pages
4587-4629
ISSN
  • 0301-4851 (ISSN-L)
  • 1573-4978
OpenAlex
W3017786087
Cited by
571
References
342
FWCI
23.93
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Role of PI3K/AKT pathway in cancer: the framework of malignant behavior. https://app.cochat.ai/papers/10.1007/s11033-020-05435-1
The paper
Jiang, N., Dai, Q., Su, X., Fu, J., Feng, X., & Peng, J. (2020). Role of PI3K/AKT pathway in cancer: the framework of malignant behavior. Molecular Biology Reports. https://doi.org/10.1007/s11033-020-05435-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.